BAX:NYSE
Baxter International Inc
26,34 $
arrow_downward
−0,30%(−0,080) 1 p
26,20 $
arrow_downward
−0,53% (−0,14)bedtimePärast tööaega
Suletud: 11. nov, 16:00:02 GMT −5 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse BAX põhistatistika genereerimine…
Ava
26,11 $
Kõrge
26,50 $
Madal
25,98 $
Turu kapit.
13,63 mld
Keskm. maht
7,09 mln
Maht
3,83 mln
Dividend
0,15%
Kvartaalne dividend
0,01 $
Dividendikuupäev
28. aug 2026
52 näd kõrgeim
30,00 $
52 näd madalaim
15,73 $
Aktsiatulu
−1,42 $
Beeta
0,68
Käibivad aktsiad
517,35 mln
Töötajate arv
38 tuh
Ava
26,11 $
Kõrge
26,50 $
Madal
25,98 $
Turu kapit.
13,63 mld
Keskm. maht
7,09 mln
Maht
3,83 mln
Dividend
0,15%
Kvartaalne dividend
0,01 $
Dividendikuupäev
28. aug 2026
52 näd kõrgeim
30,00 $
52 näd madalaim
15,73 $
Aktsiatulu
−1,42 $
Beeta
0,68
Käibivad aktsiad
517,35 mln
Töötajate arv
38 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
The Globe and Mail
·
1 tunni eest
The Nasdaq Just Did Something For Just the 5th Time Ever. History Says This Could Happen Next.
Moomoo
·
1 tunni eest
Nasdaq Futures Fall as Nvidia Sinks 8% After Hours on Report Board May Oust Huang
Bloomberg.com
·
8 tunni eest
Nasdaq 100 Advances 3% as Easing AI Anxiety Draws Dip Buyers In
markets.businessinsider.com
·
8 tunni eest
NextNRG Announces Nasdaq Delisting Determination; Trading to Be Suspended at Market Open on November 12, 2026
Profiil
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Teave üksuse Baxter International Inc kohta
TegevjuhtAndrew Hider
Töötajad37,5 tuh
Asutatud1931
PeakontoridDeerfield, Illinois, Ameerika Ühendriigid
SektorHealth Care
Valdkond-
Veebisaitbaxter.com